| Dr Malissa T Mathis, OD | |
|
1506 N Limestone St, Gaffney, SC 29340-4747 | |
| (864) 489-2016 | |
| (864) 488-1123 |
| Full Name | Dr Malissa T Mathis |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 26 Years |
| Location | 1506 N Limestone St, Gaffney, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487659256 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1092 (South Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carolina Vision Associates Llc | 5799683959 | 7 |
News Archive
Keryx Biopharmaceuticals, Inc. today announced that two posters on KRX-0401 were presented at the 102nd annual meeting of the American Association for Cancer Research currently ongoing at the Orange County Convention Center in Orlando, Florida. Perifosine, the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase pathway, is currently in Phase 3 clinical trials for refractory advanced colorectal cancer and multiple myeloma.
Researchers say they have discovered a link between childhood autism and mental illness in parents; they suggest that the parents of autistic children are twice as likely to have had a psychiatric illness.
AltheRx Pharmaceuticals, a privately-held clinical development company, today announced the United States Patent and Trademark Office issued a Notice of Allowance for the company's U.S. Patent Application claiming a method of use for solabegron, a beta 3-adrenergic receptor agonist, in combination with all commercially available antimuscarinics at both therapeutic and sub-therapeutic doses for the treatment of overactive bladder (OAB).
Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced its financial results for the first quarter ended March 31, 2010.
The U.S. Food and Drug Administration today approved Xeljanz (tofacitinib) to treat adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to, or who are intolerant of, methotrexate.
› Verified 6 days ago
| Provider Name | Carolina Vision Associates Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1255357356 PECOS PAC ID: 5799683959 Enrollment ID: O20031224000032 |
News Archive
Keryx Biopharmaceuticals, Inc. today announced that two posters on KRX-0401 were presented at the 102nd annual meeting of the American Association for Cancer Research currently ongoing at the Orange County Convention Center in Orlando, Florida. Perifosine, the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase pathway, is currently in Phase 3 clinical trials for refractory advanced colorectal cancer and multiple myeloma.
Researchers say they have discovered a link between childhood autism and mental illness in parents; they suggest that the parents of autistic children are twice as likely to have had a psychiatric illness.
AltheRx Pharmaceuticals, a privately-held clinical development company, today announced the United States Patent and Trademark Office issued a Notice of Allowance for the company's U.S. Patent Application claiming a method of use for solabegron, a beta 3-adrenergic receptor agonist, in combination with all commercially available antimuscarinics at both therapeutic and sub-therapeutic doses for the treatment of overactive bladder (OAB).
Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced its financial results for the first quarter ended March 31, 2010.
The U.S. Food and Drug Administration today approved Xeljanz (tofacitinib) to treat adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to, or who are intolerant of, methotrexate.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Malissa T Mathis, OD 180 N Dean St, Spartanburg, SC 29302-1517 Ph: (864) 583-3125 | Dr Malissa T Mathis, OD 1506 N Limestone St, Gaffney, SC 29340-4747 Ph: (864) 489-2016 |
News Archive
Keryx Biopharmaceuticals, Inc. today announced that two posters on KRX-0401 were presented at the 102nd annual meeting of the American Association for Cancer Research currently ongoing at the Orange County Convention Center in Orlando, Florida. Perifosine, the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase pathway, is currently in Phase 3 clinical trials for refractory advanced colorectal cancer and multiple myeloma.
Researchers say they have discovered a link between childhood autism and mental illness in parents; they suggest that the parents of autistic children are twice as likely to have had a psychiatric illness.
AltheRx Pharmaceuticals, a privately-held clinical development company, today announced the United States Patent and Trademark Office issued a Notice of Allowance for the company's U.S. Patent Application claiming a method of use for solabegron, a beta 3-adrenergic receptor agonist, in combination with all commercially available antimuscarinics at both therapeutic and sub-therapeutic doses for the treatment of overactive bladder (OAB).
Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced its financial results for the first quarter ended March 31, 2010.
The U.S. Food and Drug Administration today approved Xeljanz (tofacitinib) to treat adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to, or who are intolerant of, methotrexate.
› Verified 6 days ago
Piedmont Family Eyecare Optometrist Medicare: Not Enrolled in Medicare Practice Location: 165 Walton Dr, Gaffney, SC 29341 Phone: 864-489-6871 | |
Dr. Raymond Gary Poole, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1115 W Floyd Baker Blvd, Gaffney, SC 29341 Phone: 864-487-2020 Fax: 864-487-3510 | |
Carolina Vision Associates, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 1506 N Limestone St, Gaffney, SC 29340 Phone: 864-489-2016 Fax: 864-488-1123 | |
Dr. N.w. Davis, P.a. Optometrist Medicare: Medicare Enrolled Practice Location: 300 N Logan St, Gaffney, SC 29341 Phone: 864-489-6593 Fax: 864-489-5040 | |
Dr. Joseph Michael Dipasqua, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 165 Walton Dr, Gaffney, SC 29341 Phone: 864-489-6871 | |
Poole Family Eye Care Of Gaffney Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1502 W Floyd Baker Blvd, Gaffney, SC 29341 Phone: 864-489-9979 Fax: 864-480-9920 |